Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

November 4, 2021 updated by: Veysel Bayburtluoğlu, Ankara Training and Research Hospital
The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Ankara, Turkey
        • Recruiting
        • Veysel Bayburtluoğlu
        • Contact:
          • Veysel Bayburtluoğlu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

• Patients with erectile dysfuction

Exclusion Criteria:

  • Psychogenic erectile dysfunction
  • Erectile dysfunction associated with hormonal disorders
  • Drug related erectile dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: 5mg tadalafil
Diagnostic test: Endocan
Endocan will measured before and after treatment
Drug: tadalafil
tadalafil
Other: 20mg tadalafil
20 mg tadalafil
Diagnostic test: Endocan
Endocan will measured before and after treatment
Drug: tadalafil
tadalafil

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rates of IIEF Score
Time Frame: 1 month
Levels of Endocan relationship with IIEF
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of Endocan
Time Frame: 1 month
Levels of Endocan with tadalafil treatment
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ankara Training and Research Hospital

Investigators

  • Principal Investigator: Veysel Bayburtluoğlu, Ministry of Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2021

Primary Completion (Anticipated)

November 15, 2021

Study Completion (Anticipated)

December 15, 2021

Study Registration Dates

First Submitted

September 4, 2021

First Submitted That Met QC Criteria

November 4, 2021

First Posted (Actual)

November 5, 2021

Study Record Updates

Last Update Posted (Actual)

November 5, 2021

Last Update Submitted That Met QC Criteria

November 4, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E-93471371-514.10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erectile Dysfunction

Clinical Trials on Endocan

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe